Fresenius Kabi Deutschland GmbH

Tweet this page
Registration as it was on 22 Feb 2023
How to read and use this data card.
Download this datacard


Lobbying Costs

100,000€ - 199,999€

Financial year: Jan 2022 - Dec 2022

Lobbyists (Full time equivalent)

0.75 Fte (3)

Lobbyists with EP accreditation


High-level Commission meetings


Lobbying Costs over the years

  • Info

    Fresenius Kabi Deutschland GmbH

    EU Transparency Register

    130305227617-65 First registered on 29 Jun 2017

    Goals / Remit

    Fresenius Kabi is a global healthcare company that specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. Our products and services are used to help care for critically and chronically ill patients. In Europe, Fresenius Kabi is the market leader in infusion therapy and clinical nutrition
    Fresenius Kabi employs over 42,000 people worldwide. With our corporate philosophy "caring for life", we are committed to putting essential medicines and technologies in the hands of people who help patients and finding the best answers to the challenges they face. Further we are committed to improving patients' quality of life wherever needed: whether in hospitals, medical centres or at patient's homes.
    Fresenius Kabi AG is a wholly owned subsidiary of the Fresenius SE & Co. KGaA healthcare group.

    Main EU files targeted

    Public Health, Industrial and IP Policies, Pricing and Reimbursement Policies, Pharmaceutical and Biosimilars legislation, EU Trade Policy, European external trade agenda, Pharmaceuticals in the environment, global health.


    Head Office
    Fresenius Kabi Deutschland GmbH Else-Kröner-Str. 1
    Bad Homburg 61352
    EU Office
    Fresenius Kabi Deutschland GmbH Else-Kröner-Str. 1
    Bad Homburg 61352


  • People

    Total lobbyists declared


    Employment timeLobbyists

    Lobbyists (Full time equivalent)


    Lobbyists with EP accreditation

    All Lobbyists with EP accreditation over time

    2 accreditations were / are live (in bold) for the selected state of 30 Mar 2023

    Name Start date End Date
    Mr Matthew TURNER 11 Feb 2023 10 Feb 2024
    Mr Stefan KOLB 20 Jan 2023 19 Jan 2024
    Mr Hrishikesh KULKARNI 24 Mar 2022 23 Mar 2023
    Mr Matthew TURNER 05 Nov 2019 31 Oct 2020
    Mr Stefan KOLB 10 Oct 2019 01 Nov 2020
    Mr David M JAUCH 23 Oct 2018 23 Oct 2019

    Complementary Information

    Other persons are involved, but less than 10%.

    Person in charge of EU relations

    Data not provided by Register Secretariat due to GDPR

    Person with legal responsibility

    Data not provided by Register Secretariat due to GDPR

  • Categories


    Companies & groups

  • Networking


    Medicines for Europe, Medical Nutrition International, AMR Industry Alliance

    Member organisations

    None declared

  • Financial Data

    Interests represented

    Promotes their own interests or the collective interests of their members

    Closed financial year

    Jan 2022 - Dec 2022

    Lobbying costs for closed financial year

    100,000€ - 199,999€

    Major contributions in closed year

    None declared

    Intermediaries for closed year

    None declared

    Intermediaries for current year

    None declared

    Closed year Costs

    100,000€ - 199,999€

    Other financial info

    None declared

  • EU Structures

    Groups (European Commission)


    Groups (European Parliament)


    Other activities

    Fresenius Kabi is cooperating with the institutions of the European Union to support policies that improves patient access to affordable medicines.

  • Meetings


    1 meetings found. Download meetings

    The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't publish information about such meetings. All information below comes from European Commission web pages.

Download this datacard